These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20825346)

  • 1. Intracellular lifestyles and immune evasion strategies of uropathogenic Escherichia coli.
    Hunstad DA; Justice SS
    Annu Rev Microbiol; 2010; 64():203-21. PubMed ID: 20825346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramacrophage survival of uropathogenic Escherichia coli: differences between diverse clinical isolates and between mouse and human macrophages.
    Bokil NJ; Totsika M; Carey AJ; Stacey KJ; Hancock V; Saunders BM; Ravasi T; Ulett GC; Schembri MA; Sweet MJ
    Immunobiology; 2011 Nov; 216(11):1164-71. PubMed ID: 21802164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular bacterial communities of uropathogenic Escherichia coli in urinary tract pathogenesis.
    Anderson GG; Dodson KW; Hooton TM; Hultgren SJ
    Trends Microbiol; 2004 Sep; 12(9):424-30. PubMed ID: 15337164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasion of vaginal epithelial cells by uropathogenic Escherichia coli.
    Brannon JR; Dunigan TL; Beebout CJ; Ross T; Wiebe MA; Reynolds WS; Hadjifrangiskou M
    Nat Commun; 2020 Jun; 11(1):2803. PubMed ID: 32499566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.
    Schwartz DJ; Chen SL; Hultgren SJ; Seed PC
    Infect Immun; 2011 Oct; 79(10):4250-9. PubMed ID: 21807904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of intracellular bacterial communities in a child with Escherichia coli recurrent urinary tract infections.
    Robino L; Scavone P; Araujo L; Algorta G; Zunino P; Vignoli R
    Pathog Dis; 2013 Aug; 68(3):78-81. PubMed ID: 23733378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Innate transcriptional networks activated in bladder in response to uropathogenic Escherichia coli drive diverse biological pathways and rapid synthesis of IL-10 for defense against bacterial urinary tract infection.
    Duell BL; Carey AJ; Tan CK; Cui X; Webb RI; Totsika M; Schembri MA; Derrington P; Irving-Rodgers H; Brooks AJ; Cripps AW; Crowley M; Ulett GC
    J Immunol; 2012 Jan; 188(2):781-92. PubMed ID: 22184725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host subversion by formation of intracellular bacterial communities in the urinary tract.
    Anderson GG; Martin SM; Hultgren SJ
    Microbes Infect; 2004 Oct; 6(12):1094-101. PubMed ID: 15380779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Murine Model for Escherichia coli Urinary Tract Infection.
    Hannan TJ; Hunstad DA
    Methods Mol Biol; 2016; 1333():159-75. PubMed ID: 26468108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the Escherichia coli polysaccharide capsule as a virulence factor during urinary tract infection: contribution to intracellular biofilm development.
    Goller CC; Seed PC
    Virulence; 2010; 1(4):333-7. PubMed ID: 21178466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bacterial characteristics of importance for recurrent urinary tract infections caused by Escherichia coli.
    Ejrnæs K
    Dan Med Bull; 2011 Apr; 58(4):B4187. PubMed ID: 21466767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morphological plasticity promotes resistance to phagocyte killing of uropathogenic Escherichia coli.
    Horvath DJ; Li B; Casper T; Partida-Sanchez S; Hunstad DA; Hultgren SJ; Justice SS
    Microbes Infect; 2011 May; 13(5):426-37. PubMed ID: 21182979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.
    Hannan TJ; Totsika M; Mansfield KJ; Moore KH; Schembri MA; Hultgren SJ
    FEMS Microbiol Rev; 2012 May; 36(3):616-48. PubMed ID: 22404313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection.
    Mulvey MA; Schilling JD; Hultgren SJ
    Infect Immun; 2001 Jul; 69(7):4572-9. PubMed ID: 11402001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uropathogenic Escherichia coli virulence and innate immune responses during urinary tract infection.
    Ulett GC; Totsika M; Schaale K; Carey AJ; Sweet MJ; Schembri MA
    Curr Opin Microbiol; 2013 Feb; 16(1):100-7. PubMed ID: 23403118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular bacterial biofilm-like pods in urinary tract infections.
    Anderson GG; Palermo JJ; Schilling JD; Roth R; Heuser J; Hultgren SJ
    Science; 2003 Jul; 301(5629):105-7. PubMed ID: 12843396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uropathogenic
    Kim WJ; Shea AE; Kim JH; Daaka Y
    J Biol Chem; 2018 Oct; 293(42):16518-16527. PubMed ID: 30166343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of O-Antigen Serotype with the Magnitude of Initial Systemic Cytokine Responses and Persistence in the Urinary Tract.
    Horvath DJ; Patel AS; Mohamed A; Storm DW; Singh C; Li B; Zhang J; Koff SA; Jayanthi VR; Mason KM; Justice SS
    J Bacteriol; 2016 Jan; 198(6):964-72. PubMed ID: 26755631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for collecting duct epithelial cells in renal antibacterial defences.
    Chassin C; Tourneur E; Bens M; Vandewalle A
    Cell Microbiol; 2011 Aug; 13(8):1107-13. PubMed ID: 21615666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation changes as important factors for the susceptibility to urinary tract infection.
    Taganna J; de Boer AR; Wuhrer M; Bouckaert J
    Biochem Soc Trans; 2011 Jan; 39(1):349-54. PubMed ID: 21265802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.